About Springer
Springer is a company based in Heidelberg (Germany) founded in 1842 was acquired by BC Partners in June 2013. It operates as a Subscription Services and Direct-to-Consumer (D2C). The company has 1 employees as of April 06, 2024. Springer has completed 3 acquisitions, including BioMed Central, Current Medicine Group and MekenTosj. Springer offers products and services including Journals and Books.
- Headquarter Heidelberg, Germany
- Employees 1 as on 06 Apr, 2024
-
Sectors
Education
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Springer Nature
- Date of Incorporation 19 Apr, 2007
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$1.92 B (USD)-0.32as on Dec 31, 2024
-
Net Profit
$70.96 M (USD)340.65as on Dec 31, 2024
-
EBITDA
$660.53 M (USD)0.52as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
EQT
& 3 more
-
Employee Count
1
as on Apr 06, 2024
-
Investments & Acquisitions
BioMed Central
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Springer
Springer offers a comprehensive portfolio of products and services, including Journals and Books.
Scientific journals are published for global research access.
Books are offered for various academic disciplines worldwide.
Funding Insights of Springer
Investors in Springer
Springer has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include EQT, European Union and BC Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
Sovereign wealth is managed and private equity investments are facilitated.
|
Locked | Locked | Locked | |
|
Diversified alternative assets are managed through investment strategies.
|
Locked | Locked | Locked |
Investor details for Springer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Springer
Springer has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include BioMed Central, Current Medicine Group and MekenTosj.
Investment portfolio details for Springer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Software development services are provided by MekenTosj in Portugal.
|
Locked | Locked | 2007 | Locked | |
|
Open-access journals in biology, health, and medicine are published.
|
Locked | Locked | 2000 | Locked | |
|
Medical resources and services are provided by Current Medicine Group.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Springer
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Springer
Detailed financials for Springer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Springer Comparisons
Peer comparison for Springer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Springer
Detailed competitors of Springer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Springer
Complete news archive for Springer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Springer
Springer was founded in 1842 and raised its 1st funding round 172 years after it was founded.
Springer is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
As of Apr 06, 2024, the latest employee count at Springer is 1.
Annual revenue of Springer is $1.92B as on Dec 31, 2024.
Springer, under Springer Nature, is involved in the publication of over 2,900 scientific journals and 300,000 books. Content is provided across diverse academic fields including astronomy, biomedical sciences, business, engineering, and social sciences. Solutions are offered for authors, researchers, and institutions through open access options and subscription models. The focus is placed on making research and educational materials widely accessible globally.
Springer offers Journals and Books.
Springer has made 3 acquisitions, including BioMed Central, Current Medicine Group, and MekenTosj.
Springer has 4 investors. Key investors include EQT, European Union, BC Partners, and GIC.